Content in this section will include AAPM advocacy efforts, legislative news, public statements, etc.

AAPM Statement on Interventional Pain Procedures and SCS

​A statement from the American Academy of Pain Medicine  While valid concerns have been raised by the International Consortium of Investigative Journalists regarding spinal cord stimulators (SCS), the American Academy of Pain Medicine (AAPM) feels that focusing on these concerns alone does not tell the whole story.  Pain remains one of th...
Continue reading

Report from the AMA Interim Meeting

November 2018, National Harbor, MD Submitted by Robert Wailes, MD, AAPM AMA Delegate The AMA House of Delegates (HOD) met November 10-13 in National Harbor, MD, to discuss many challenging issues and draft new policies intended to shape the practice of medicine in the United States. Topics as diverse as gun control and physician aid in dying were a...
Continue reading

AAPM Retains Seat in AMA House of Delegates

Thanks to AAPM members like you maintaining membership in the American Medical Association (AMA), the Academy was recently informed that it has been determined eligible for continued representation in the AMA House of Delegates (HOD) for the next five years. This marks the 30th anniversary of AAPM in the AMA HOD.

AAPM Comments on NIH Report on National Efforts to Address the Opioid Crisis

Comments from the American Academy of Pain Medicine  The American Academy of Pain Medicine appreciates the opportunity to provide comments regarding the Roadmap and of the federal action to address not only the national opioid crisis but also the challenges in treatment of pain that are one contributing factor to the crisis.  From an over...
Continue reading

Pain Medicine Physician Perspective Represented in AMA House of Delegates

Pain medicine was represented at the recent American Medical Association House of Delegates Interim meeting by delegate Robert Wailes, MD , and alternate delegate Donna Bloodworth, MD . Among topics discussed, delegates spoke against insurers and pharmacists using CDC guidelines to restrict the provision of opioids. See AMA Delegates Back Physician...
Continue reading

The National Science and Technology Council (NSTC) Seeks Public Comment

The NSTC is seeking public comment on the Draft Report of the Fast Track Action Committee (FTAC) on Health Science and Technology Response to the Opioid Crisis. Comments are requested by December 5. Full story .

Trump Signs Anti-Opioid Abuse Legislation Into Law

Source: Office of National Drug Control Policy (ONDCP] President Trump signed the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment ("SUPPORT") for Patients and Communities Act, a compromise version of HR 6, into law today. Full story .

CMS Model Addresses Opioid Misuse Among Expectant and New Mothers

Source: CMS The Centers for Medicare & Medicaid Services (CMS) announced the Maternal Opioid Misuse (MOM) model, an important step in advancing the agency's multi-pronged strategy to combat the nation's opioid crisis. Full story .

National Center for Health Statistics Releases Provisional Drug Overdose Death Counts

Source: CDC This data visualization presents provisional counts for drug overdose deaths based on a current flow of mortality data in the National Vital Statistics System. Full story . 

Concerns About Walmart’s New Policy on Opioid Prescriptions

A statement from the American Academy of Pain Medicine  The American Academy of Pain Medicine (AAPM) echoes concerns raised by the American Medical Association (AMA) in response to Walmart's corporate policy that restricts initial opioid prescriptions for acute pain to no more than a seven-day supply and 50 morphine milligram equivalents (MME)...
Continue reading